Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Hyderabad Pharma City...

    Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-10-22T09:45:13+05:30  |  Updated On 22 Oct 2019 9:45 AM IST
    Hyderabad Pharma City Project: KTR seeks Rs 1318 crore assistance from Centre

    The minister contended that Hyderabad Pharma City is the "world's largest integrated pharma park" to promote domestic manufacturing of pharmaceuticals in line with the "Make in India" initiative.


    Hyderabad: Telangana Minister for IT and Industries KT Rama Rao, popularly known as KTR recently wrote to Union Ministers Piyush Goyal and Dharmendra Pradhan seeking an assistance of Rs 1318 for the Hyderabad Pharma City (HPC) project, proposed to be developed near here.


    A month ago, the minister apprised that the Pharma City Project had received an overwhelming response from the industry stakeholders and is expected to generate investments worth Rs 64,000 crore and provide direct and indirect employment to 5.60 lakh people.


    Also Read: Upcoming Pharma City project to generate Rs 64000 crore investments: Minister informs Telangana assembly


    To proceed with the project, KTR recently sought a grant of Rs 1,318 crore for implementation of external infrastructure linkages and Rs 2,100 crore for the project towards Phase-1 internal infrastructure development from the Minister of Railways and Commerce, Piyush Goyal while natural gas allocation on preferential tariff basis and reliable supply for project operations from Dharmendra Pradhan, Minister of Petroleum & Natural Gas and Minister. The official letter written by KTR reads;




    Have requested Hon’ble Minister of Petroleum & Natural Gas Sri @dpradhanbjp Ji to allocate reliable supply of natural gas at preferential tariff for Hyderabad Pharma City, a project of national importance


    By using Natural Gas instead of Coal, HPC will reduce emissions/pollution pic.twitter.com/xz0MHg54Ky

    — KTR (@KTRTRS) October 21, 2019


    The minister contended that HPC is the "world's largest integrated pharma park" to promote domestic manufacturing of pharmaceuticals in line with the "Make in India" initiative.


    "Government of Telangana reassures its commitment towards the development of a world-class Hyderabad Pharma City and promoting competitive domestic manufacturing of pharmaceuticals under the Make in India initiative of GOI," KTR told ANI.


    Also Read: Telangana Minister KTR inaugurates Medical Devices Park

    dharmendra pradhanHPCKT Rama RaoKTRminister of petroleumminister of railwayspharmapharma city projectpharma newspharma news indiaHyderabad pharma citypharma projectpiyush goyalTelanganaunion govt
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok